 Elanco Animal Health Incorporated NYSE: ELAN today announced that the company has received unanimous approval from the U.S. Federal Trade Commission FTC for its acquisition of Bayer Animal Health, a division of Bayer AG ETR: BAYN. The FTC decision represents the final antitrust clearance needed to complete the transaction, which continues on track for closing at the beginning of August. 